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Our doubt: could a more incisive intervention for the protection of A.’s development
have the risk of a further invalidation of the mother, if the hypothesis about her
pathological psychological condition is correct?
Conclusion: After frequent attempts of creation of a better relationship with A.’s
parents we must evidence our failure: we did not ﬁnd the adequate way to manage
this case and we feel blocked between the comprehension of the mother’s difﬁculties
about her daughter’s illness and the hypothesis of Munchausen syndrome by Proxy,
or recognize the possibility of the mother’s psychiatric pathology.
She is currently separated from her husband and has refused the aid of a social
worker, eliminating any presence in the relationship between her and child. However
she continues to present an inadequate management of her daughter who has a
serious nutrition condition.
P29 COMMUNICATION OF DIAGNOSIS TO CHILDREN: MEDICAL
ROLE
C. Risso, G. Cordola, I. Tardivo A. Veljkovic. Pediatric CF Centre, O.I.R.M. Turin,
Italy
When we speak of “communication of diagnosis” we usually mean the situation
in which the physician communicates to parents that their child is suffering
from cystic ﬁbrosis. Literature contains lot of articles facing this thematic from
the psychological point of view. Seldom has been considered the importance to
communicate and to give information to the child. Obviously during the ﬁrst years
of his life the child is not aware of illness, and he faces it through the emotions
of the adults. Therefore he is inﬂuenced by the feelings of his mother or other
important referee. When he becomes three-four years old he becomes aware of the
disease and, additionally, of his own body; he begins to be sensitive to the offered
explanations about the necessity of the visits, of the therapies or of the hospital
admissions and overall he needs to be informed about his performance status of
health avoiding to feel guilty for the disease and to feel therapies as maltreatments.
Beginning from this phase of development and even more afterward, too often are
parents to bear the responsibility to give answers and explanations to the children,
not always satisfactorily supported and helped by the health team of the Center. We
think, instead, it should be very important that physicians themselves must put up,
with the small patients, a good relationship characterized by unambiguous, sincere
and continual communication adapting it to the age of the child.
The communication of diagnosis is not a ﬁnishing event that reaches ends con-
clusions, but rather a never-ending situation that begins in the childhood and it
continues in the growing years.
If, meeting the child, we speak to him basically, explaining his disease and what
we are planning to do just to cure him and moreover we listen to his fears and we
answer his questions, only in this case we demonstrate respect to him as a human
being liberating him by a negative function of inactive object and beginning to build
a correct therapeutic strategy.
With this approach even a hard event, like a hospital admission, will not be
considered as a tragic experience to be removed but rather as an unavoidable
necessity without any alternative choice.
At last, the health staff should be aware of what kind of information about the
disease has been given to the patient by the parents, because a common strategy
should be planned together and implemented in concert. Resistances of the family
and the possible inclination to reject to speak to the child about illness should be
respected but as well discussed together.
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Introduction: The psychological, physical, and social impact of CF is complex and
varies among patients of different ages. In the last decade, health-related quality
of life (HRQoL), deﬁned as the "people subjective evaluation on the inﬂuences of
their current health status on the ability to achieve and maintain a level of overall
functioning" has become an essential outcome for chronic conditions.
This study is aimed at assessing HRQL in Italian CF patients cared for at the
Bambino Gesu` Children’s Hospital.
Patients and Methods: The inclusion criteria were: being regularly followed up,
7 years of age, ability to read Italian and absence of mental illness.
The age-speciﬁc versions of the Cystic Fibrosis Questionnaire (CFQ; Henry et
al, 1996) were used with permission. They were translated into Italian, and back-
translated into the original language (French) to check for semantic equivalence.
Higher scores indicate better quality of life.
Results: Out of 121 eligible patients, 118 accepted to participate (97.5%). Forty-
eight (40.7%) were aged 7−13 years; 27 (22.9%) were 14−17 years old, and 43
were 18 years or more (36.4%). Fifty-one percent were females.
Patients consistently reported scores higher than 70 on most of the domains.
Lower scores were obtained in “Treatment Constraints” and “Social Limitations”
sub-scales. Compared with older patients, younger ones had higher scores on
“Energy/wellbeing”, and lower on “Social Limitations”, “Eating Disturbances” and
“Digestive Symptoms”.
As expected, patients with the most compromised lung functioning (FEV1 <65)
showed lower HRQL scores, particularly in “Emotional functioning”, “Body im-
age”, “Treatment constraints” and “Respiratory symptoms”. No gender-related
differences were found.
Conclusions: HRQoL domain of “Social limitations” appears of most concern in
children and adolescents affected by CF, as “Treatment constraints” in patients with
compromised lung function.
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SFHR (Small Fragment Homologous Replacement) is a gene targeting strategy
based on homologous recombination (HR) of small DNA fragments (SDFs) into
the genomic DNA of recipient cells. The SFHR technique has also been applied
to modify the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
gene. The inadequate knowledge of the mechanisms of action of the SFHR limits
its reproducibility and efﬁciency. The relevance of SFHR for the correction of
CFTR defects, together with the still unexplored possibility of an inﬂuence on HR
of epigenetic DNA modiﬁcations, prompted us to investigate the effect of SDF
methylation on SFHR-mediated gene repair process efﬁciency.
We used our previously constructed assay system obtained by stable integration of
a mutated copy of enhanced green ﬂuorescent protein (EGFP) gene in immortalized
embryonic ﬁbroblasts DNA.
The SFHR efﬁciency was quantiﬁed by FACS analysis as the percentage of EGFP-
positive cells after correction. The effect of methylation status of the corrective frag-
ment was tested by comparison between PCR-ampliﬁed and plasmid-excised SDFs.
The presence of methylation on SDF was checked by digestion with methylation-
sensitive restriction enzymes, followed by PCR ampliﬁcation: the presence or ab-
sence of a PCR amplicon indicates, respectively, a methylated or unmethylated SDF.
In plasmid-excised SDF, we evidenced both DAM and DCM, but not HpaII,
methylation. No methylation was evidenced on PCR-ampliﬁed SDF. When a PCR-
ampliﬁed (unmethylated) SDF was transfected in cells synchronized in G2 phase,
the efﬁciency of correction was 0.1%. After transfecting a plasmid-excised (methy-
lated) SDF, a 15-fold increase of ﬂuorescent cells was evidenced, reaching 1.5%
of correction. Also the effect of speciﬁc methylation patterns, created on the SDF
fragment by treatment with speciﬁc methylases, was evaluated and will be discussed.
The 12% of residual CFTR functionality is usually accepted as the lower threshold
to be overcome to restore a normal phenotype in Cystic Fibrosis patients: the en-
hancement of SFHR efﬁciency due to SDF methylation opens up a new perspective
for the correction of mutated CFTR.
*Tel 06–49970458, Fax 06–4464698, E-mail lucarelli@bce.uniroma1.it
This work and G.F. were partially supported by “Fondazione per la Ricerca sulla
Fibrosi Cistica” (grant FFC 5/2005).
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Pseudomonas aeruginosa infection and chronic inﬂammation are hallmarks of lung
disease in cystic ﬁbrosis (CF).
Extracellular GSH is a scavenger of free radicals produced by neutrophils in
inﬂamed tissues.
Glutathione transferases (GST) are a superfamily of dimeric proteins which conju-
gate glutathione to a wide range of substrates including oxidants and are involved
the synthesis of leukotriens.
Azithromycin (AZM) ameliorates lung function in cystic ﬁbrosis (CF) patients. This
macrolide has been suggested to have anti-inﬂammatory properties as well as other
effects potentially relevant for therapy of CF.
The present investigation was aimed to verify the effects of AZM on GST activity
in CF cell lines.
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CF cell line IB3−1 presented with increased GSTT1 and GSTM1 mRNA and
protein expression levels in comparison with the isogenic non-CF cell line C38.
AZM exposure signiﬁcantly decreased GSTT1 and GSTM1 mRNA and protein
expression in IB3−1, restoring the levels observed in C38 cells. In another CF cell
line, 2CFSMEo-, AZM produced 45% reductions in GSTT1 and GSTM1 mRNA
levels. The macrolide JM, known to lack clinical anti-inﬂammatory properties,
had no signiﬁcant effects on GSTT1 and GSTM1 mRNA expression in all cell
lines. GSTP1 was not differentially expressed in all CF and non-CF cells and its
expression was unaffected by AZM. AZM reduced GST activity of about 25% and
40% in IB3−1 and 2CFSMEo− cells, respectively.
Finally, GSTs activity and the expression of GSTT1 and GSTM1 proteins in
CF cells, were reduced by interleukin 10 (IL-10), an anti-inﬂammatory cytokine,
approximately to the same level detected after treatment with AZM, shedding light
on a possible correlation between GSTs inhibition and anti-inﬂammatory properties
of AZM.
Downregulation of GSTT1 and GSTM1 expression may result in increased avail-
ability of intracellular GSH making CF cells less susceptible to oxidative stress
induced by chronic inﬂammation. Thus these results suggest novel anti-oxidant
properties for AZM.
*CC and GB equally contributed to this work.
This study is supported by Italian CF Research Foundation (FFC10/2005; 17/2006);
Comitato di Vicenza-Associazione Veneta per la lotta contro la Fibrosi Cistica;
Azienda Ospedaliera Verona, Italy.
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Lung disease in cystic ﬁbrosis (CF) is characterized by excessive inﬂammation
and infection by several pathogens. The most relevant bacterium in CF is the
Pseudomonas (P.) aeruginosa that is able to colonize the CF airways by means
of its adaptation to the microaerobic environment.
Little is known about the changes in protein secretion induced by oxygen limitation
in PAO1, the proto-typical P. aeruginosa laboratory strain, and no data are available
on P. aeruginosa clinical strains, like AA2, used in this study. Our work was aimed
to study the differential regulation of proteins secreted by Pa strains grown in
microaerobic or aerobic conditions.
The set of polypeptides released by P. aeruginosa strains grown in microaerobic or
aerobic conditions were analyzed by two-dimensional capillary chromatography–
tandem mass spectrometry (MudPIT). We identiﬁed 75 polypeptides released by
PAO1 and 198 by AA2 strains grown in aerobic conditions. When the same strains
were cultured in microaerobic conditions we could identify 6 proteins up-regulated
and none down-regulated in PAO1 strain, while 4 proteins that were down-regulated
and 7 proteins up-regulated in AA2 strain. Among the peptides identiﬁed we found a
strong down modulation of alkaline metalloprotease peptides under microaerophilic
conditions by AA2 strain. The data were conﬁrmed by proteolytic activity assay
of the supernatants demonstrating that conditioned medium derived from AA2
grown in aerobic conditions has a much higher activity than the one obtained by
microaerophilic culture. Furthermore activity in PAO1-derived samples was barely
detectable and no such regulation was observed, indicating the functional relevance
of the data obtained by MudPIT analysis.
The identiﬁcation of virulence factors might be facilitated by this combined
approach that appears to be capable to restrict the number of potential candidates and
facilitate the identiﬁcation of molecular targets for pharmacological intervention.
*CC and GB equally contributed to this work.
This study is supported by Italian CF Research Foundation (FFC10/2005; 17/2006);
Comitato di Vicenza-Associazione Veneta per la lotta contro la Fibrosi Cistica;
Azienda Ospedaliera Verona, Italy.
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Cellular therapy of lung disease may be the resolutive cure for cystic ﬁbrosis (CF).
We investigated the effect of epithelial damage caused by Pseudomonas aeruginosa,
pathogenic bacterium widely occurring in CF patients, on the engraftment of bone
marrow (BM)-derived cells in pulmonary epithelium. Upon intratracheal injection
of total BM obtained from transgenic GFP-positive mice into P. aeruginosa-infected
mice, GFP-positive cells were found in the recepient lungs but their numbers were
very small. Only when bone marrow cells were puriﬁed by means of negative
immunoselection to obtain a cell suspension enriched in stem/progenitor cells
(20%, as evaluated by Sca1 expression), signiﬁcant numbers of GFP-positive
cells were detected in the lung epithelium. The fractions of GFP-positive cells
expressing cytokeratin were 0.34−0.76 %. To understand the cellular constraints
limiting homing of HSCs to the lung, we studied their energetic status and CFTR
expression. Confocal microscopy showed the high level of heterogeneity of the
mitochondrial content of these cells. To obtain a more homogeneously phenotypic
population, whole bone marrow was processed by through anti-Sca-1 positive
selection, which resulted in 80−90% HSCs. Cytoﬂuorimetric analysis revealed that
there were two different cell populations as regard to their size. Moreover, the
intracellular content of mitochondria was not homogeneously distributed in the Sca-
1+ cell population displaying a clear inverse correlation of their density with the
expression of the Sca-1 marker. Positively selected HSCs expressed CFTR protein,
as judged by epiﬂuorescence. Chloride secretion measurements at the single-cell
level and in the entire population demonstrated the presence of a functional
CFTR channel.
HSCs, due to their CFTR expression, could be useful in the treatment of CF by
means of bone marrow transplantation. It has ﬁrst to be seen which behaviour the
HSC sub-populations with different mitochondrial content displays in the homing
to the lung.
Supported by the EC grant QLRT 2002 02119 and Fondazione Italiana per la
Ricerca sulla Fibrosi Cistica (grant 2–2006).
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
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Burkholderia cenocepacia is an important opportunistic pathogen among cystic
ﬁbrosis (CF) patients. The severity of infection has been related to a wide range
of potential virulence determinants and to the ability of B. cenocepacia bacteria to
invade respiratory epithelial cells and cause sepsis. Infection by these bacteria usu-
ally occurs in patients who are already colonized by Pseudomonas aeruginosa, the
major pathogen in CF. In order to understand the pathophysiology of B. cenocepacia
respiratory infections in CF, it is important to explore the interactions between the
different pathogens that may have synergic effects on their virulence. In the present
work, we aimed to determine whether P. aeruginosa PAO1 synergistically enhances
the growth rate and internalization of B. cenocepacia LMG16656T into human
epithelial cells. Results obtained from mixed cultures revealed no signiﬁcative
change in the B. cenocepacia growth rate, as compared to mono-culture data; on
the contrary, a signiﬁcant decrease of P. aeruginosa growth was observed. In a
co-infection assay, by using the pulmonary epithelial cell line A549, we found
a higher level of invasion by B. cenocepacia in the presence of P. aeruginosa as
compared to B. cenocepacia alone. Altogether, the results obtained strongly indicate
that pathogenic potential of B. cenocepacia may be enhanced by the co-presence
of P. aeruginosa that positively affects its internalization into human respiratory
epithelial cells, as well as by the growth inhibition of other pathogens, like
P. aeruginosa. Thus, the co-presence of two or more bacterial species in the lung of
CF patients may have a profound effect on the bacterial growth and internalization.
This work was supported by Italian Cystic Fibrosis Research Foundation (ffc),
Verona, Italy (FFC7–2006), and adopted by Delegazione FFC of Latina, Italy.
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Cystic ﬁbrosis (CF) lung disease is characterized by dehydration, followed by bac-
terial colonization, bronchiectasis and ultimately death. Assuming that reduction of
Na+ absorption could help to restore airway hydration, we planned to downregulate
